A Class III Semaphorin (Sema3e) Inhibits Mouse Osteoblast Migration and Decreases Osteoclast Formation In Vitro
Open Access
- 7 January 2012
- journal article
- research article
- Published by Springer Nature in Calcified Tissue International
- Vol. 90 (2) , 151-162
Abstract
Originally identified as axonal guidance cues, semaphorins are expressed throughout many different tissues and regulate numerous non-neuronal processes. We demonstrate that most class III semaphorins are expressed in mouse osteoblasts and are differentially regulated by cell growth and differentiation: Sema3d expression is increased and Sema3e expression decreased during proliferation in culture, while expression of Sema3a is unaffected by cell density but increases in cultures of mineralizing osteoblasts. Expression of Sema3a, -3e, and -3d is also differentially regulated by osteogenic stimuli; inhibition of GSK3β decreased expression of Sema3a and -3e, while 1,25-(OH)2D3 increased expression of Sema3e. Parathyroid hormone had no effect on expression of Sema3a, -3b, or -3d. Osteoblasts, macrophages, and osteoclasts express the Sema3e receptor PlexinD1, suggesting an autocrine and paracrine role for Sema3e. No effects of recombinant Sema3e on osteoblast proliferation, differentiation, or mineralization were observed; but Sema3e did inhibit the migration of osteoblasts in a wound-healing assay. The formation of multinucleated, tartrate-resistant acid phosphatase–positive osteoclasts was decreased by 81% in cultures of mouse bone marrow macrophages incubated with 200 ng/mL Sema3e. Correspondingly, decreased expression of osteoclast markers (Itgb3, Acp5, Cd51, Nfatc1, CalcR, and Ctsk) was observed by qPCR in macrophage cultures differentiated in the presence of Sema3e. Our results demonstrate that class III semaphorins are expressed by osteoblasts and differentially regulated by differentiation, mineralization, and osteogenic stimuli. Sema3e is a novel inhibitor of osteoclast formation in vitro and may play a role in maintaining local bone homeostasis, potentially acting as a coupling factor between osteoclasts and osteoblasts.Keywords
This publication has 46 references indexed in Scilit:
- PTH and PTHrP signaling in osteoblastsCellular Signalling, 2009
- Tie2Cre-mediated inactivation of plexinD1 results in congenital heart, vascular and skeletal defectsDevelopmental Biology, 2009
- PlexinD1 Glycoprotein Controls Migration of Positively Selected Thymocytes into the MedullaImmunity, 2008
- Autocrine semaphorin3A stimulates alpha2 beta1 integrin expression/function in breast tumor cellsBreast Cancer Research and Treatment, 2008
- Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?British Journal of Cancer, 2008
- Semaphorin 3B Is a 1,25-Dihydroxyvitamin D3-Induced Gene in Osteoblasts that Promotes Osteoclastogenesis and Induces Osteopenia in MiceMolecular Endocrinology, 2008
- A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesisCytokine & Growth Factor Reviews, 2005
- Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitorNature Medicine, 2003
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitroJournal of Endocrinology, 1985